Henrik Sengeløv

Henrik Sengeløv

Clinical Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
71 - 80 out of 103Page size: 10
Sort by: Title
  1. Published

    Long-term survival after allogeneic haematopoietic cell transplantation for AML in remission: single-centre results after TBI-based myeloablative and non-myeloablative conditioning

    Sengeløv, Henrik, Gerds, Thomas Alexander, Brændstrup, P., Kornblit, B., Mortensen, B. K., Petersen, S. L. & Vindeløv, L. L., Sep 2013, In: Bone Marrow Transplantation. 48, 9, p. 1185-91 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host disease

    Nygaard, M., Karlsmark, Tonny, Andersen, N. S., Schjødt, I. M., Petersen, S. L., Friis, L. S., Kornblit, B. T. & Sengeløv, Henrik, 2019, In: Bone Marrow Transplantation. 54, 1, p. 35-43 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT

    Gilleece, M. H., Shimoni, A., Labopin, M., Robinson, S., Beelen, D., Socié, G., Unal, A., Ganser, A., Vitek, A., Sengeløv, Henrik, Yakoub-Agha, I., Tholouli, E., Polge, E., Mohty, M. & Nagler, A., 2021, In: Blood Cancer Journal. 11, 5, 88.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Metabolic Potential of the Gut Microbiome Is Significantly Impacted by Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

    Jørgensen, M., Nørgaard, J. C., Ilett, E. E., Marandi, R. Z., Noguera-Julian, M., Paredes, R., Murray, D. D., Lundgren, Jens, MacPherson, C. R. & Sengeløv, Henrik, 2022, In: International Journal of Molecular Sciences. 23, 19, 17 p., 11115.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Metabolic Profiling Early Post-Allogeneic Haematopoietic Cell Transplantation in the Context of CMV Infection

    Rasmussen, K. K., dos Santos, Q., MacPherson, C. R., Zucco, Adrian G., Gjærde, L. K., Ilett, Emma Elizabeth, Lodding, I., Helleberg, Marie, Lundgren, Jens, Nielsen, S. D., Brix, S., Sengeløv, Henrik & Murray, D. D., 2023, In: Metabolites. 13, 9, 11 p., 968.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Mononuclear Cell Telomere Attrition Is Associated with Overall Survival after Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

    Helby, J., Petersen, S. L., Kornblit, B., Nordestgaard, Børge, Mortensen, B. K., Bojesen, Stig Egil & Sengeløv, Henrik, 2019, In: Biology of Blood and Marrow Transplantation. 25, 3, p. 496-504 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Mortality and admission to intensive care units after febrile neutropenia in patients with cancer

    Aagaard, T., Reekie, J., Jørgensen, M., Roen, A., Daugaard, G., Specht, Lena, Sengeløv, Henrik, Mocroft, A., Lundgren, Jens & Helleberg, M., May 2020, In: Cancer Medicine. 9, 9, p. 3033-3042 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Ocular Chronic Graft-versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes after Allogeneic Hematopoietic Cell Transplantation

    Jeppesen, H., Gjærde, L. K., Lindegaard, J., Julian, H. O., Heegaard, Steffen & Sengeløv, Henrik, 2022, In: Transplantation and Cellular Therapy. 28, 12, p. 833.e1-833.e7

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Ocular graft-versus-host disease and dry eye disease after paediatric haematopoietic stem cell transplantation - incidence and risk factors

    Jeppesen, H., Kielsen, K., Siersma, Volkert Dirk, Lindegaard, J., Julian, H. O., Heegaard, Steffen, Sengeløv, Henrik & Muller, Klaus, 2022, In: Bone Marrow Transplantation. 57, p. 487–498 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT

    Masouridi-Levrat, S., Olavarria, E., Iacobelli, S., Aljurf, M., Morozova, E., Niittyvuopio, R., Sengeloev, H., Reményi, P., Helbig, G., Browne, P., Ganser, A., Nagler, A., Snowden, J. A., Robin, M., Passweg, J., Van Gorkom, G., Wallet, H. L., Hoek, J., Blok, H. J., De Witte, T. & 4 others, Kroeger, N., Hayden, P., Chalandon, Y. & Agha, I. Y., 2022, In: Bone Marrow Transplantation. 57, 1, p. 23-30 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...4 5 6 7 8 9 10 11 Next

ID: 10801252